SOURCE: Revolutions Medical Corp.

Revolutions Medical Corp.

October 27, 2009 10:35 ET

RevMed CEO Ron Wheet Details Growth Strategy in Online Audio Interview

Comprehensive Discussion Provides Valuable First Person Resource for Investors

CHARLESTON, SC--(Marketwire - October 27, 2009) - Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that CEO Ron Wheet has been featured in the popular AllPennyStocks.com Spotlight series, produced by TheNewsWire.ca. The thorough interview provides valuable, fresh insight into both the RevVac and MRI product lines -- straight from the Company's CEO.

Click here to listen to the interview or copy and paste the following URL into a browser window: http://ir.stockpr.com/revolutionsmedical/media-center/view/33/.

To be added to the RevMed investor email list, please email justin.davis@cirrusfc.com with RMCP in the subject line.

About Revolutions Medical Corporation (www.revolutionsmedical.com)

RevMed's products include the RevVac safety syringe (FDA Approved), safety blood drawing device and safety IV catheter. RevMed also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.

Investor Resource Center

Fact Sheet: http://content.stockpr.com/rmcp/files/RMCP_-_Fact_Sheet_09-09-09.pdf

CEO Ron Wheet Audio Interview: http://ir.stockpr.com/revolutionsmedical/media-center/view/33/

RevVac Demo Video: http://www.revolutionsmedical.com/videos/revac_directions_final.wmv

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact Information